FDA Drug Shortage Database
Amphetamine and dextroamphetamine (Adderall) shortage
The FDA Drug Shortage Database lists 28 of 71 amphetamine and dextroamphetamine presentations as limited or unavailable (updated October 5, 2026); the first entry was posted on October 12, 2022. 43 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
- DEA Schedule II
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 5mg tablet | 5 | 7 | 0 |
| 7.5mg tablet | 2 | 6 | 0 |
| 10mg tablet | 5 | 6 | 0 |
| 12.5mg tablet | 2 | 4 | 0 |
| 15mg tablet | 5 | 6 | 0 |
| 20mg tablet | 4 | 7 | 0 |
| 30mg tablet | 5 | 7 | 0 |
Which presentations are listed?
Limited or unavailable now (28)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Unavailable; Other |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01) | SpecGx LLC | Current posted October 12, 2022, updated August 20, 2026 | Limited Availability; Demand increase for the drug |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01) | Aurobindo Pharma USA | Current posted October 12, 2022, updated October 2, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01) | Epic Pharma, LLC | Current posted October 12, 2022, updated October 5, 2026 | Limited Availability; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01) | Granules Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 18, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01) | Oryza Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 16, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01) | Aurobindo Pharma USA | Current posted October 12, 2022, updated October 2, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01) | Granules Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 18, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01) | SpecGx LLC | Current posted October 12, 2022, updated August 20, 2026 | Limited Availability; Demand increase for the drug |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01) | Aurobindo Pharma USA | Current posted October 12, 2022, updated October 2, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01) | Epic Pharma, LLC | Current posted October 12, 2022, updated October 5, 2026 | Limited Availability; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01) | Granules Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 18, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01) | Oryza Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 16, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01) | Granules Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 18, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Limited Availability; Other |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01) | Aurobindo Pharma USA | Current posted October 12, 2022, updated October 2, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01) | Epic Pharma, LLC | Current posted October 12, 2022, updated October 5, 2026 | Limited Availability; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01) | Granules Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 18, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01) | Oryza Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 16, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01) | Aurobindo Pharma USA | Current posted October 12, 2022, updated October 2, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01) | Epic Pharma, LLC | Current posted October 12, 2022, updated October 5, 2026 | Limited Availability; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01) | Granules Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 18, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01) | Oryza Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 16, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01) | SpecGx LLC | Current posted October 12, 2022, updated August 20, 2026 | Limited Availability; Demand increase for the drug |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01) | Aurobindo Pharma USA | Current posted October 12, 2022, updated October 2, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01) | Epic Pharma, LLC | Current posted October 12, 2022, updated October 5, 2026 | Limited Availability; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01) | Granules Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 18, 2026 | Unavailable; Shortage of an active ingredient |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01) | Oryza Pharmaceuticals Inc. | Current posted October 12, 2022, updated September 16, 2026 | Unavailable; Shortage of an active ingredient |
Listed now, available (43)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01) | Sandoz Inc. | Current posted October 12, 2022, updated September 18, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37) | Lannett Company, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01) | Sunrise Pharmaceutical, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01) | Elite Laboratories, Inc. | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01) | SpecGx LLC | Current posted October 12, 2022, updated August 20, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37) | Lannett Company, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01) | Sunrise Pharmaceutical, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01) | Elite Laboratories, Inc. | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01) | Alvogen | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01) | Alvogen | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01) | Sandoz Inc. | Current posted October 12, 2022, updated September 18, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01) | Sunrise Pharmaceutical, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01) | Elite Laboratories, Inc. | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01) | Alvogen | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37) | Lannett Company, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01) | Sunrise Pharmaceutical, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01) | Elite Laboratories, Inc. | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01) | SpecGx LLC | Current posted October 12, 2022, updated August 20, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37) | Lannett Company, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01) | Sunrise Pharmaceutical, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01) | Elite Laboratories, Inc. | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01) | Alvogen | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01) | Sandoz Inc. | Current posted October 12, 2022, updated September 18, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01) | SpecGx LLC | Current posted October 12, 2022, updated August 20, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01) | Sunrise Pharmaceutical, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01) | Elite Laboratories, Inc. | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01) | Alvogen | Current posted October 12, 2022, updated October 2, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01) | Sandoz Inc. | Current posted October 12, 2022, updated September 18, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37) | Lannett Company, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02) | Teva Pharmaceuticals USA, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01) | Sunrise Pharmaceutical, Inc. | Current posted October 12, 2022, updated October 1, 2026 | Available |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01) | Elite Laboratories, Inc. | Current posted August 15, 2023, updated October 2, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Methylphenidate | ADHD | In shortage | 31 labelers | $0.158 per tablet 10 mg tablet |
| Lisdexamfetamine | ADHD | In shortage | 19 labelers | $2.44 per capsule 20 mg capsule |
| Dexmethylphenidate | ADHD | No current entry | 13 labelers | $1.45 per capsule 10 mg capsule |
| Dexmethylphenidate and serdexmethylphenidate | ADHD | No current entry | none listed | $14.40 per capsule 26.1 mg-5.2 mg capsule |
| Methamphetamine | ADHD | No current entry | 3 labelers | $5.10 per tablet 5 mg tablet |
| Atomoxetine | ADHD | No current entry | 20 labelers | $0.442 per capsule 40 mg capsule |
| Guanfacine | ADHD | A presentation being discontinued | 36 labelers | $0.147 per tablet 1 mg tablet |
| Viloxazine | ADHD | No current entry | none listed | $12.74 per capsule 200 mg capsule |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage